Literature DB >> 22885592

Possible involvement of sulfotransferase 1A1 in estragole-induced DNA modification and carcinogenesis in the livers of female mice.

Yuta Suzuki1, Takashi Umemura, Yuji Ishii, Daisuke Hibi, Tomoki Inoue, Meilan Jin, Hiroki Sakai, Yukio Kodama, Takehiko Nohmi, Tokuma Yanai, Akiyoshi Nishikawa, Kumiko Ogawa.   

Abstract

Estragole (ES), a natural organic compound, is frequently used as a flavoring in food even though it is a hepatocarcinogen in mice. Although formation of ES-specific DNA adducts following conversion from ES to the nucleophilic metabolite by sulfotransferase 1A1 (SULT1A1) has been reported, the modes of action underlying ES-induced hepatocarcinogenesis remain uncertain because conventional genotoxicity tests for ES yield negative results. In the present study, taking notice of the fact that there is a sex difference in SULT1A1 activity in the mouse liver, we assessed the frequency of micronuclei in polychromatic erythrocytes and the mutant frequency (MF) of reporter genes in female gpt delta mice treated with ES at doses of 0 (corn oil), 37.5, 75, 150 or 300mg/kg body weight (bw) by gavage for 13 weeks. Results were compared with those obtained in males. Since one female was found dead at week one, the highest dose was reduced to 250mg/kg bw in females from week two. As reported previously in C57BL/6 mice, the mRNA levels of Sult1a1 in female gpt delta mice were significantly higher than those in the males. The levels of ES-specific DNA adducts in the females were higher than those in the males at all doses except the highest dose. In addition, MFs of the gpt gene were significantly increased from doses of 75mg/kg bw of females, but the increment was observed only at the highest dose in males. There were no changes in the micronucleus test among the groups. Thus, the overall data suggest that specific DNA modifications by the SULT1A1-mediated carbocation formation and the resultant genotoxicity are key events in the early stage of ES-induced hepatocarcinogenesis of mice.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885592     DOI: 10.1016/j.mrgentox.2012.07.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

Review 1.  RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.

Authors:  Bingliang Fang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-07       Impact factor: 3.848

2.  Mechanistic relationships between hepatic genotoxicity and carcinogenicity in male B6C3F1 mice treated with polycyclic aromatic hydrocarbon mixtures.

Authors:  Tracie D Phillips; Molly Richardson; Yi-Shing Lisa Cheng; Lingyu He; Thomas J McDonald; Leslie H Cizmas; Stephen H Safe; Kirby C Donnelly; Fen Wang; Bhagavatula Moorthy; Guo-Dong Zhou
Journal:  Arch Toxicol       Date:  2014-06-03       Impact factor: 5.153

3.  Expression of sulfotransferase SULT1A1 in cancer cells predicts susceptibility to the novel anticancer agent NSC-743380.

Authors:  Xiao Huang; Mengru Cao; Li Wang; Shuhong Wu; Xiaoying Liu; Hongyu Li; Hui Zhang; Rui-Yu Wang; Xiaoping Sun; Caimiao Wei; Keith A Baggerly; Jack A Roth; Michael Wang; Stephen G Swisher; Bingliang Fang
Journal:  Oncotarget       Date:  2015-01-01

Review 4.  Predictive biomarkers in precision medicine and drug development against lung cancer.

Authors:  Bingliang Fang; Reza J Mehran; John V Heymach; Stephen G Swisher
Journal:  Chin J Cancer       Date:  2015-07-02

5.  In vivo mutagenicity and tumor-promoting activity of 1,3-dichloro-2-propanol in the liver and kidneys of gpt delta rats.

Authors:  Kohei Matsushita; Shinji Takasu; Yuji Ishii; Takeshi Toyoda; Takanori Yamada; Tomomi Morikawa; Kumiko Ogawa
Journal:  Arch Toxicol       Date:  2021-07-16       Impact factor: 5.153

Review 6.  Thresholds of Genotoxic and Non-Genotoxic Carcinogens.

Authors:  Takehiko Nohmi
Journal:  Toxicol Res       Date:  2018-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.